479 related articles for article (PubMed ID: 35594946)
1. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
2. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
[TBL] [Abstract][Full Text] [Related]
4. The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.
Shafaghi A; Vakili Shahrbabaki SS; Aminzadeh A; Heidari MR; Shamsi Meymandi M; Bashiri H
Neurotoxicol Teratol; 2022; 89():107050. PubMed ID: 34801733
[TBL] [Abstract][Full Text] [Related]
5. Behavioral improvements in a valproic acid rat model of autism following vitamin D supplementation.
Du L; Zhao G; Duan Z; Li F
Psychiatry Res; 2017 Jul; 253():28-32. PubMed ID: 28324861
[TBL] [Abstract][Full Text] [Related]
6. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
[TBL] [Abstract][Full Text] [Related]
7. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
[TBL] [Abstract][Full Text] [Related]
8. Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/ Bcl-2 pathway.
Elesawy RO; El-Deeb OS; Eltokhy AK; Arakeep HM; Ali DA; Elkholy SS; Kabel AM
Biomed Pharmacother; 2022 Jun; 150():112960. PubMed ID: 35447549
[TBL] [Abstract][Full Text] [Related]
9. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism.
Gholipour P; Ebrahimi Z; Mohammadkhani R; Ghahremani R; Salehi I; Sarihi A; Komaki A; Karimi SA
Sci Rep; 2024 Jun; 14(1):13168. PubMed ID: 38849397
[TBL] [Abstract][Full Text] [Related]
10. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model.
Bódi V; Májer T; Kelemen V; Világi I; Szűcs A; Varró P
Front Neural Circuits; 2022; 16():772792. PubMed ID: 35185478
[TBL] [Abstract][Full Text] [Related]
12. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.
Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M
Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334
[TBL] [Abstract][Full Text] [Related]
13. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
14. Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat model.
Lan J; Hu Y; Wang X; Zheng W; Liao A; Wang S; Li Y; Wang Y; Yang F; Chen D
Neuropharmacology; 2021 Sep; 196():108689. PubMed ID: 34175324
[TBL] [Abstract][Full Text] [Related]
15. Music alleviates cognitive impairments in an animal model of autism.
Taheri F; Joushi S; Esmaeilpour K; Sheibani V; Ebrahimi MN; Taheri Zadeh Z
Int J Dev Neurosci; 2023 Aug; 83(5):399-416. PubMed ID: 37246451
[TBL] [Abstract][Full Text] [Related]
16. The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism.
Lima-Castañeda LÁ; Bringas ME; Aguilar-Hernandez L; Garcés-Ramírez L; Morales-Medina JC; Flores G
J Chem Neuroanat; 2023 Oct; 132():102317. PubMed ID: 37482145
[TBL] [Abstract][Full Text] [Related]
17. Group I and group II metabotropic glutamate receptors are upregulated in the synapses of infant rats prenatally exposed to valproic acid.
D'Antoni S; Schiavi S; Buzzelli V; Giuffrida S; Feo A; Ascone F; Busceti CL; Nicoletti F; Trezza V; Catania MV
Psychopharmacology (Berl); 2023 Dec; 240(12):2617-2629. PubMed ID: 37707611
[TBL] [Abstract][Full Text] [Related]
18. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Shekari MA
Behav Pharmacol; 2023 Jun; 34(4):179-196. PubMed ID: 37171458
[TBL] [Abstract][Full Text] [Related]
20. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.
Kim KC; Kim P; Go HS; Choi CS; Park JH; Kim HJ; Jeon SJ; Dela Pena IC; Han SH; Cheong JH; Ryu JH; Shin CY
J Neurochem; 2013 Mar; 124(6):832-43. PubMed ID: 23311691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
